Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study ; volume:43 ; number:9 ; day:8 ; month:9 ; year:2023 ; pages:719-728 ; date:9.2023
Clinical drug investigation ; 43, Heft 9 (8.9.2023), 719-728, 9.2023
- Creator
-
Sekerel, Bulent Enis
Nell, Haylene
Laki, Istvan
Pak, Tatiana
Contreras, Edgar
Kolarz, Adam
D’Andrea, Peter
Manga, Volkan
Jain, Monish
Vaidya, Soniya
Valentin, Michele
Sen, Biswajit
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-023-01300-8
- URN
-
urn:nbn:de:101:1-2023121212011416278709
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sekerel, Bulent Enis
- Nell, Haylene
- Laki, Istvan
- Pak, Tatiana
- Contreras, Edgar
- Kolarz, Adam
- D’Andrea, Peter
- Manga, Volkan
- Jain, Monish
- Vaidya, Soniya
- Valentin, Michele
- Sen, Biswajit
- SpringerLink (Online service)
Other Objects (12)
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy